Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSA-01 in Multiple System Atrophy
NCT07446894Phase 3Recruiting
- Sponsor
- The University of Tokyo
- Start
- Feb 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ubiquinol in multiple system atrophy (MSA), sponsored by The University of Tokyo. Started Feb 2026; status: recruiting.
02
Drugs
ubiquinol
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT07446894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446894.